Dublin, Feb. 07, 2025 (GLOBE NEWSWIRE) — The “Sequencing Reagents Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.
The Sequencing Reagents Market was valued at USD 8.66 Billion in 2024, and is expected to reach USD 15.84 Billion by 2030, rising at a CAGR of 10.54%. The market is experiencing significant growth and transformation, driven by advancements in genomic research and personalized medicine. The market is witnessing a surge in demand as genomic sequencing becomes an integral component of various scientific disciplines, including genomics, oncology, agriculture, and microbiology.
The increasing prevalence of genetic disorders, coupled with a growing emphasis on precision medicine, is fueling the adoption of sequencing technologies worldwide. Key players in the industry are continuously investing in research and development to innovate and launch cutting-edge sequencing reagents that offer improved performance, reduced costs, and enhanced scalability.
Next-generation sequencing (NGS) technologies are driving the market forward, facilitating high-throughput sequencing and paving the way for a deeper understanding of genetic variations. The global COVID-19 pandemic has underscored the importance of rapid and accurate sequencing in diagnostics and surveillance, further boosting the market.
Geographically, North America and Europe dominate the market, owing to the presence of well-established biotechnology and pharmaceutical industries, along with robust research infrastructure. As the global sequencing reagents market continues to evolve, collaboration between industry stakeholders, government bodies, and academic institutions will be crucial in addressing these challenges and ensuring sustained growth in this dynamic and rapidly advancing field.
Key Market Drivers
- Advancements in Genomic Research
- Increasing Prevalence of Genetic Disorders
- Technological Innovations in Next-Generation Sequencing
Key Market Challenges
- Data Management and Analysis Complexity
- Cost Constraints
Key Market Trends
- Rapid Adoption in Clinical Diagnostics
- Expanding Applications in Oncology
Key Players Profiled in the Sequencing Reagents Market
- Thermo Fisher Scientific, Inc.
- Abzena Ltd.
- Illumina, Inc.
- QIAGEN N.V.
- Pacific Biosciences of California, Inc.
- F. Hoffmann-La Roche Ltd.
- Oxford Nanopore Technologies PLC
- Agilent Technologies, Inc.
- Fluidigm Corporation
- Integrated DNA Technologies, Inc.
Report Scope
Sequencing Reagents Market, By Technology:
- Sanger Sequencing
- Next-Generation Sequencing
- Third Generation Sequencing
Sequencing Reagents Market, By Type:
- Library Kits
- Template Kits
- Control Kits
- Sequencing Kits
- Others
Sequencing Reagents Market, By Application:
- Oncology
- Reproductive Health
- Clinical Investigation
- Agrigenomics & Forensics
- Others
Sequencing Reagents Market, By Region:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Key Attributes
| Report Attribute | Details |
| No. of Pages | 183 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $8.66 Billion |
| Forecasted Market Value (USD) by 2030 | $15.84 Billion |
| Compound Annual Growth Rate | 10.5% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/mzseot
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Sequencing Reagents Market
